UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The FDA and Gene Therapy for Duchenne Muscular Dystrophy

JAMA : the journal of the American Medical Association, 2024-05, Vol.331 (20), p.1705

Rind, David M

2024

Volltextzugriff (PDF)

Regions of rapid sea ice change: An inter-hemispheric seasonal comparison

Geophysical research letters, 2012-03, Vol.39 (6), p.n/a

2012

Volltextzugriff (PDF)

How natural and anthropogenic influences alter global and regional surface temperatures: 1889 to 2006

Geophysical research letters, 2008-09, Vol.35 (18), p.L18701-n/a

2008

Volltextzugriff (PDF)

How will Earth's surface temperature change in future decades?

Geophysical research letters, 2009-08, Vol.36 (15), p.L15708-n/a

2009

Volltextzugriff (PDF)

The GRADE Working Group clarifies the construct of certainty of evidence

Journal of clinical epidemiology, 2017-07, Vol.87, p.4-13

2017

Volltextzugriff (PDF)

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline

American journal of respiratory and critical care medicine, 2015-07, Vol.192 (2), p.e3-e19

2015

Volltextzugriff (PDF)

Should We Screen for Type 2 Diabetes?

Annals of internal medicine, 2017-04, Vol.166 (7), p.535

Rind, David M.

2017

Volltextzugriff (PDF)

GRADE guidelines: 15. Going from evidence to recommendation—determinants of a recommendation's direction and strength

Journal of clinical epidemiology, 2013-07, Vol.66 (7), p.726-735

2013

Volltextzugriff (PDF)

Atmospheric CO₂: Principal Control Knob Governing Earth's Temperature

Science (American Association for the Advancement of Science), 2010-10, Vol.330 (6002), p.356-359

2010

Volltextzugriff (PDF)

A network meta-analysis of KarXT and commonly used pharmacological interventions for schizophrenia

Schizophrenia research, 2024-12, Vol.274, p.212-219

2024

Volltextzugriff (PDF)

How Do the Institute for Clinical and Economic Review’s Assessments of Comparative Effectiveness Compare With the German Federal Joint Committee’s Assessments of Added Benefit? A Qualitative Study

Value in health, 2024-08, Vol.27 (8), p.1066-1072

2024

Volltextzugriff (PDF)

Increasing contribution of the atmospheric vertical motion to precipitation in a warming climate

Communications earth & environment, 2024-09, Vol.5 (1), p.541-13, Article 541

2024

Volltextzugriff (PDF)

GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes

Journal of clinical epidemiology, 2013-02, Vol.66 (2), p.151-157

2013

Volltextzugriff (PDF)

The Cost-Effectiveness of Remdesivir for Hospitalized Patients With COVID-19

Value in health, 2022-05, Vol.25 (5), p.744-750

2022

Volltextzugriff (PDF)

A guide for health professionals to interpret and use recommendations in guidelines developed with the GRADE approach

Journal of clinical epidemiology, 2016-04, Vol.72, p.45-55

2016

Volltextzugriff (PDF)

Grading of recommendations assessment, development, and evaluation concept article 5: addressing intransitivity in a network meta-analysis

Journal of clinical epidemiology, 2023-08, Vol.160, p.151-159

2023

Volltextzugriff (PDF)

Exploring the ENSO modulation of the QBO periods with GISS E2.2 models

Atmospheric chemistry and physics, 2024-01, Vol.24 (1), p.509-532

2024

Volltextzugriff (PDF)

The impact of capping health system cost savings on the projected cost-effectiveness of etranacogene dezaparvovec compared with factor IX prophylaxis for the treatment of hemophilia B

Journal of managed care & specialty pharmacy, 2024-08, Vol.30 (8), p.868-872

2024

Volltextzugriff (PDF)

Informing the United States Medicare Drug Price Negotiation for Apixaban and Rivaroxaban: Methodological Considerations for Value Assessments Many Years After Launch

Value in health, 2024-07

2024

Volltextzugriff (PDF)

Cost-Effectiveness of Nadofaragene Firadenovec and Pembrolizumab in Bacillus Calmette-Guérin Immunotherapy Unresponsive Non–Muscle Invasive Bladder Cancer

Value in health, 2023-06, Vol.26 (6), p.823-832

2023

Volltextzugriff (PDF)

Mavacamten for hypertrophic cardiomyopathy: effectiveness and value: A summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum

Journal of managed care & specialty pharmacy, 2022-03, Vol.28 (3), p.369-375

2022

Volltextzugriff (PDF)

GRADE concept 6: A novel application of external indirect evidence into GRADE ratings of evidence certainty in Network Meta-analysis

Journal of clinical epidemiology, 2023-11, Vol.163, p.95-101

2023

Volltextzugriff (PDF)

The effectiveness and value of aducanumab for Alzheimer’s disease: A summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum

Journal of managed care & specialty pharmacy, 2021-11, Vol.27 (11), p.1613-1617

2021

Volltextzugriff (PDF)

The effectiveness and value of midomafetamine-assisted psychotherapy for posttraumatic stress disorder

Journal of managed care & specialty pharmacy, 2024-10, Vol.30 (10), p.1191

2024

Volltextzugriff (PDF)

1 – 25 von 336

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(295)
Mit Volltextzugriff
(235)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(335)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(195)
Physical Sciences
(96)
Life Sciences & Biomedicine
(87)
Meteorology & Atmospheric Sciences
(73)
Earth, Ocean, Space
(71)
Exact Sciences And Technology
(71)
Humans
(66)
External Geophysics
(58)
Meteorology
(50)
Climate Change
(47)
Health Care Sciences & Services
(41)
Climate Models
(34)
Climate
(33)
Surface Temperature
(24)
Technology
(24)
Climatology. Bioclimatology. Climate Change
(23)
General Circulation Models
(23)
S On Value
(23)
Pharmacology & Pharmacy
(21)
Cost-Benefit Analysis
(20)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

The FDA and Gene Therapy for Duchenne Muscular Dystrophy

Regions of rapid sea ice change: An inter-hemispheric seasonal comparison

How natural and anthropogenic influences alter global and regional surface temperatures: 1889 to 2006

How will Earth's surface temperature change in future decades?

The GRADE Working Group clarifies the construct of certainty of evidence

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline

Should We Screen for Type 2 Diabetes?

GRADE guidelines: 15. Going from evidence to recommendation—determinants of a recommendation's direction and strength

Atmospheric CO₂: Principal Control Knob Governing Earth's Temperature

A network meta-analysis of KarXT and commonly used pharmacological interventions for schizophrenia

How Do the Institute for Clinical and Economic Review’s Assessments of Comparative Effectiveness Compare With the German Federal Joint Committee’s Assessments of Added Benefit? A Qualitative Study

Increasing contribution of the atmospheric vertical motion to precipitation in a warming climate

GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes

The Cost-Effectiveness of Remdesivir for Hospitalized Patients With COVID-19

A guide for health professionals to interpret and use recommendations in guidelines developed with the GRADE approach

Grading of recommendations assessment, development, and evaluation concept article 5: addressing intransitivity in a network meta-analysis

Exploring the ENSO modulation of the QBO periods with GISS E2.2 models

The impact of capping health system cost savings on the projected cost-effectiveness of etranacogene dezaparvovec compared with factor IX prophylaxis for the treatment of hemophilia B

Informing the United States Medicare Drug Price Negotiation for Apixaban and Rivaroxaban: Methodological Considerations for Value Assessments Many Years After Launch

Cost-Effectiveness of Nadofaragene Firadenovec and Pembrolizumab in Bacillus Calmette-Guérin Immunotherapy Unresponsive Non–Muscle Invasive Bladder Cancer

Mavacamten for hypertrophic cardiomyopathy: effectiveness and value: A summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum

GRADE concept 6: A novel application of external indirect evidence into GRADE ratings of evidence certainty in Network Meta-analysis

The effectiveness and value of aducanumab for Alzheimer’s disease: A summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum

The effectiveness and value of midomafetamine-assisted psychotherapy for posttraumatic stress disorder

A U.S. CLIVAR Project to Assess and Compare the Responses of Global Climate Models to Drought-Related SST Forcing Patterns: Overview and Results

Suchergebnisse filtern